Figure 2.
Competing-risk analysis for 1-year TRM and relapse in relation to high Reg3α concentrations. Competing-risk analysis confirmed the association of high Reg3α concentrations at day 0 and TRM when relapse was considered as competing risk.
Competing-risk analysis for 1-year TRM and relapse in relation to high Reg3α concentrations. Competing-risk analysis confirmed the association of high Reg3α concentrations at day 0 and TRM when relapse was considered as competing risk.
